يعرض 1 - 9 نتائج من 9 نتيجة بحث عن '"Derk-Jan A. de Groot"', وقت الاستعلام: 1.92s تنقيح النتائج
  1. 1

    المساهمون: Surgery, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Internal medicine, VU University medical center, Epidemiology and Data Science, APH - Methodology, Oncology, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Epidemiologie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

    المصدر: Rovers, K P, Bakkers, C, Nienhuijs, S W, Burger, J W A, Creemers, G-J M, Thijs, A M J, Brandt-Kerkhof, A R M, Madsen, E V E, van Meerten, E, Tuynman, J B, Kusters, M, Versteeg, K S, Aalbers, A G J, Kok, N F M, Buffart, T E, Wiezer, M J, Boerma, D, Los, M, de Reuver, P R, Bremers, A J A, Verheul, H M W, Kruijff, S, de Groot, D J A, Witkamp, A J, van Grevenstein, W M U, Koopman, M, Nederend, J, Lahaye, M J, Kranenburg, O, Fijneman, R J A, van 't Erve, I, Snaebjornsson, P, Hemmer, P H J, Dijkgraaf, M G W, Punt, C J A, Tanis, P J & de Hingh, I H J T 2021, ' Perioperative systemic therapy vs cytoreductive surgery and hyperthermic intraperitoneal chemotherapy alone for resectable colorectal peritoneal metastases: A phase 2 randomized clinical trial ', JAMA Surgery, vol. 156, no. 8, pp. 710-720 . https://doi.org/10.1001/jamasurg.2021.1642Test
    JAMA Surgery, 156(8), 710-720. American Medical Association
    JAMA surgery, 156(8), 710-720. American Medical Association
    JAMA Surgery, 156(8), 710-720. AMER MEDICAL ASSOC
    JAMA Surgery, 156, 710-720
    JAMA Surg
    JAMA Surgery, 156, 8, pp. 710-720

    مصطلحات موضوعية: Male, PROGNOSIS, medicine.medical_treatment, CARCINOMATOSIS, MULTICENTER, Hyperthermic Intraperitoneal Chemotherapy, 030230 surgery, Peritoneal Neoplasms/secondary, law.invention, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, FOLFOX, Randomized controlled trial, law, Adenocarcinoma/secondary, Adjuvant/adverse effects, Neoadjuvant therapy, Original Investigation, Bevacizumab/administration & dosage, Cytoreduction Surgical Procedures, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, OPEN-LABEL, CANCER, Neoadjuvant Therapy, Fluorouracil/administration & dosage, Capecitabine/administration & dosage, 030220 oncology & carcinogenesis, FOLFIRI, Leucovorin/administration & dosage, Hyperthermic intraperitoneal chemotherapy, Female, medicine.drug, medicine.medical_specialty, Camptothecin/administration & dosage, Capecitabine, 03 medical and health sciences, Chemotherapy, Adjuvant/adverse effects, Oxaliplatin/administration & dosage, REGRESSION, medicine, MANAGEMENT, Chemotherapy, Humans, Organoplatinum Compounds/administration & dosage, Perioperative Period, Response Evaluation Criteria in Solid Tumors, Aged, Colorectal Neoplasms/pathology, HIPEC, business.industry, Perioperative, Surgery, Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10], Irinotecan, Mitomycin/administration & dosage, Feasibility Studies, business, CONSENSUS

    وصف الملف: application/pdf

  2. 2

    المساهمون: Surgery, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), MUMC+: DA BV Medisch Specialisten Radiologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, CCA - Cancer biology and immunology, Ophthalmology, Internal medicine, VU University medical center, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and Nuclear Medicine, Oncology, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

    المصدر: European Journal of Surgical Oncology, 47(3), 699-707. ELSEVIER SCI LTD
    European Journal of Surgical Oncology, 47(3), 699-707. W.B. Saunders Ltd
    for the Dutch Pancreatic Cancer Group 2021, ' Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer : A multicenter prospective cohort ', European Journal of Surgical Oncology, vol. 47, no. 3, pp. 699-707 . https://doi.org/10.1016/j.ejso.2020.11.137Test
    European Journal of Surgical Oncology, 47, 699-707
    European journal of surgical oncology, 47(3), 699-707. W.B. Saunders Ltd
    European Journal of Surgical Oncology, 47, 3, pp. 699-707

    وصف الملف: application/pdf

  3. 3

    المساهمون: Surgery, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Epidemiologie, Graduate School, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, CCA - Cancer Treatment and quality of life, Internal medicine, VU University medical center, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

    المصدر: for the Dutch Pancreatic Cancer Group 2021, ' The treatment and survival of elderly patients with locally advanced pancreatic cancer : A post-hoc analysis of a multicenter registry ', Pancreatology, vol. 21, no. 1, pp. 163-169 . https://doi.org/10.1016/j.pan.2020.11.012Test
    Pancreatology, 21, 163-169
    Pancreatology, 21(1), 163-169. Elsevier
    Pancreatology, 21, 1, pp. 163-169
    Pancreatology, 21(1), 163-169. S. Karger AG
    Pancreatology, 21(1), 163-169. ELSEVIER SCIENCE BV

    وصف الملف: application/pdf

  4. 4

    المساهمون: Surgery, AGEM - Digestive immunity, AGEM - Endocrinology, metabolism and nutrition, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer Treatment and Quality of Life, APH - Methodology, Oncology, APH - Quality of Care, Ear, Nose and Throat, Graduate School, Pathology, Gastroenterology and Hepatology, CCA -Cancer Center Amsterdam, Gastroenterology and hepatology, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Gastroenterology & Hepatology, Medical Oncology, MUMC+: MA Heelkunde (9), RS: NUTRIM - R2 - Liver and digestive health, Interne Geneeskunde, MUMC+: MA Maag Darm Lever (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Medische Oncologie (9)

    المصدر: MacKay, T M, Smits, F J, Latenstein, A E J, Bogte, A, Bonsing, B A, Bos, H, Bosscha, K, Brosens, L A A, Hol, L, Busch, O R C, Creemers, G J, Curvers, W L, Den Dulk, M, Van Dieren, S, Van Driel, L M J W, Festen, S, Van Geenen, E J M, Van Der Geest, L G, De Groot, D J A, De Groot, J W B, Haj Mohammad, N, Haberkorn, B C M, Haver, J T, Van Der Harst, E, Hemmink, G J M, De Hingh, I H, Hoge, C, Homs, M Y V, Van Huijgevoort, N C, Jacobs, M A J M, Kerver, E D, Liem, M S L, Los, M, Lubbinge, H, Luelmo, S A C, De Meijer, V E, Mekenkamp, L, Molenaar, I Q, Van Oijen, M G H, Patijn, G A, Quispel, R, Van Rijssen, L B, Römkens, T E H, Van Santvoort, H C, Schreinemakers, J M J, Schut, H, Seerden, T, Stommel, M W J, Ten Tije, A J, Venneman, N G, Verdonk, R C, Verheij, J, Van Vilsteren, F G I, De Vos-Geelen, J, Vulink, A, Wientjes, C, Wit, F, Wessels, F J, Zonderhuis, B, Van Werkhoven, C H, Van Hooft, J E, Van Eijck, C H J, Wilmink, J W, Van Laarhoven, H W M & Besselink, M G 2020, ' Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1) : A multicenter stepped-wedge cluster randomized controlled trial ', Trials, vol. 21, no. 1, 334 . https://doi.org/10.1186/s13063-020-4180-zTest
    Trials, 21
    Trials
    Trials, 21(1):334. BioMed Central
    TRIALS, 21(1):334. BMC
    Trials, 21(1). BMC
    Trials, 21(1). BioMed Central Ltd.
    Trials, 21, 1
    Trials, Vol 21, Iss 1, Pp 1-18 (2020)
    Trials, 21(1). BioMed Central
    Trials, 21(1):334. BioMed Central Ltd

    مصطلحات موضوعية: Male, Survival, Medicine (miscellaneous), GUIDELINES, law.invention, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], Study Protocol, 0302 clinical medicine, Superiority Trial, Randomized controlled trial, DESIGN, law, Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14], Cluster Analysis, Multicenter Studies as Topic, Pharmacology (medical), 030212 general & internal medicine, Child, Netherlands, Randomized Controlled Trials as Topic, Aged, 80 and over, lcsh:R5-920, Pancreatic enzyme replacement therapy, STATEMENT, Palliative Care, Middle Aged, Neoadjuvant Therapy, Biliary Tract Surgical Procedures, Treatment Outcome, 030220 oncology & carcinogenesis, Child, Preschool, Drainage, Female, Stents, lcsh:Medicine (General), Carcinoma, Pancreatic Ductal, Adult, Quality of life, medicine.medical_specialty, Best practices, Registry, RESECTION, Referral, Adolescent, Best practice, Other Research Radboud Institute for Molecular Life Sciences [Radboudumc 0], Biliary drainage, Disease cluster, Pancreaticoduodenectomy, 03 medical and health sciences, Young Adult, Quality of life (healthcare), SDG 3 - Good Health and Well-being, Pancreatic cancer, medicine, Journal Article, Humans, Chemotherapy, Enzyme Replacement Therapy, Stepped-wedge cluster randomized controlled trial, Aged, business.industry, Health Plan Implementation, Infant, Newborn, Infant, Guideline, medicine.disease, Pancreatic Neoplasms, SAMPLE-SIZE, Implementation, Emergency medicine, Patient Compliance, business

    وصف الملف: application/pdf; text/plain

  5. 5

    المساهمون: Life Course Epidemiology (LCE), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

    المصدر: Annals of Surgical Oncology, 24(7), 1811-1820. SPRINGER
    Annals of Surgical Oncology

    وصف الملف: application/pdf

  6. 6

    المساهمون: Education in Culture, Damage and Repair in Cancer Development and Cancer Treatment (DARE), Life Course Epidemiology (LCE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), ​Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE)

    المصدر: Orphanet Journal of Rare Diseases
    Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-8 (2019)
    Orphanet journal of rare diseases, 14:60. BMC

    وصف الملف: application/pdf

  7. 7

    المساهمون: Targeted Gynaecologic Oncology (TARGON), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Life Course Epidemiology (LCE), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Clinical Cognitive Neuropsychiatry Research Program (CCNP), ​Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE)

    المصدر: World Journal of Surgical Oncology
    World journal of surgical oncology, 17(1):14
    World Journal of Surgical Oncology, Vol 17, Iss 1, Pp 1-7 (2019)

    وصف الملف: application/pdf

  8. 8

    المساهمون: Academic Medical Center, APH - Methodology, APH - Personalized Medicine, Medical Oncology, Medical oncology, CCA - Cancer Treatment and quality of life, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

    المصدر: Nature, 574(7776), 127-131. Nature Publishing Group
    van der Velden, D L, Hoes, L R, van der Wijngaart, H, van Berge Henegouwen, J M, van Werkhoven, E, Roepman, P, Schilsky, R L, de Leng, W W J, Huitema, A D R, Nuijen, B, Nederlof, P M, van Herpen, C M L, de Groot, D J A, Devriese, L A, Hoeben, A, de Jonge, M J A, Chalabi, M, Smit, E F, de Langen, A J, Mehra, N, Labots, M, Kapiteijn, E, Sleijfer, S, Cuppen, E, Verheul, H M W, Gelderblom, H & Voest, E E 2019, ' The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs ', Nature, vol. 574, no. 7776, pp. 127-131 . https://doi.org/10.1038/s41586-019-1600-xTest
    Nature, 574(7776), 127. Nature Publishing Group
    Nature, 574, 7776, pp. 127
    Nature, 574(7776), 127-+. Nature Publishing Group
    Nature, 574, 127-131. Nature Publishing Group
    Nature, 574(7776), 127
    Nature, 574, 127

    وصف الملف: image/pdf; application/pdf

  9. 9

    المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Life Course Epidemiology (LCE), ​Robotics and image-guided minimally-invasive surgery (ROBOTICS)

    المصدر: Annals of Surgical Oncology, 22(2), 552-556. SPRINGER